110 related articles for article (PubMed ID: 26065913)
1. Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.
Malyavantham K; Weinstock-Guttman B; Suresh L; Zivadinov R; Shanahan T; Badgett D; Ramanathan M
PLoS One; 2015; 10(6):e0129503. PubMed ID: 26065913
[TBL] [Abstract][Full Text] [Related]
2. Patterns of inflammation, microstructural alterations, and sodium accumulation define multiple sclerosis subtypes after 15 years from onset.
Ricciardi A; Grussu F; Kanber B; Prados F; Yiannakas MC; Solanky BS; Riemer F; Golay X; Brownlee W; Ciccarelli O; Alexander DC; Gandini Wheeler-Kingshott CAM
Front Neuroinform; 2023; 17():1060511. PubMed ID: 37035717
[TBL] [Abstract][Full Text] [Related]
3. Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients.
Fitzner B; Hecker M; Zettl UK
Autoimmun Rev; 2015 Oct; 14(10):903-13. PubMed ID: 26071103
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of multiple sclerosis: results from a large observational study in the UK.
Jick SS; Li L; Falcone GJ; Vassilev ZP; Wallander MA
J Neurol; 2015 Sep; 262(9):2033-41. PubMed ID: 26067217
[TBL] [Abstract][Full Text] [Related]
5. Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis.
Dhaeze T; Peelen E; Hombrouck A; Peeters L; Van Wijmeersch B; Lemkens N; Lemkens P; Somers V; Lucas S; Broux B; Stinissen P; Hellings N
J Immunol; 2015 Aug; 195(3):832-40. PubMed ID: 26071562
[TBL] [Abstract][Full Text] [Related]
6. Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.
Cohen JA; Khatri B; Barkhof F; Comi G; Hartung HP; Montalban X; Pelletier J; Stites T; Ritter S; von Rosenstiel P; Tomic D; Kappos L;
J Neurol Neurosurg Psychiatry; 2016 May; 87(5):468-75. PubMed ID: 26111826
[TBL] [Abstract][Full Text] [Related]
7. Autonomic dysfunction in multiple sclerosis.
Racosta JM; Kimpinski K; Morrow SA; Kremenchutzky M
Auton Neurosci; 2015 Dec; 193():1-6. PubMed ID: 26070809
[TBL] [Abstract][Full Text] [Related]
8. Peptide immunotherapy in experimental autoimmune encephalomyelitis.
Anderton SM
Biomed J; 2015; 38(3):206-14. PubMed ID: 26068029
[TBL] [Abstract][Full Text] [Related]
9. Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?
Patel JP; Frey BN
Neural Plast; 2015; 2015():708306. PubMed ID: 26075104
[TBL] [Abstract][Full Text] [Related]
10. From mishap to model: The origins and utility of experimental autoimmune encephalomyelitis.
Walton EL
Biomed J; 2015; 38(3):177-80. PubMed ID: 26068026
[TBL] [Abstract][Full Text] [Related]
11. Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?
D'haeseleer M; Hostenbach S; Peeters I; Sankari SE; Nagels G; De Keyser J; D'hooghe MB
J Cereb Blood Flow Metab; 2015 Sep; 35(9):1406-10. PubMed ID: 26104292
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and multiple sclerosis.
Tsau S; Emerson MR; Lynch SG; LeVine SM
BMC Med; 2015 Jun; 13():153. PubMed ID: 26123634
[TBL] [Abstract][Full Text] [Related]
13. Cell type-specific Nrf2 expression in multiple sclerosis lesions.
Licht-Mayer S; Wimmer I; Traffehn S; Metz I; Brück W; Bauer J; Bradl M; Lassmann H
Acta Neuropathol; 2015 Aug; 130(2):263-77. PubMed ID: 26087903
[TBL] [Abstract][Full Text] [Related]
14. Periventricular lesions correlate with cortical thinning in multiple sclerosis.
Jehna M; Pirpamer L; Khalil M; Fuchs S; Ropele S; Langkammer C; Pichler A; Stulnig F; Deutschmann H; Fazekas F; Enzinger C
Ann Neurol; 2015 Oct; 78(4):530-9. PubMed ID: 26084936
[TBL] [Abstract][Full Text] [Related]
15. Serostatus of Epstein-Barr virus in Iranian MS patients.
Karampoor S; Zahednasab H; Pirkouh AA; Monavari SH; Ramagopalan S; Keyvani H
Acta Neurol Belg; 2016 Mar; 116(1):43-6. PubMed ID: 26071762
[TBL] [Abstract][Full Text] [Related]
16. B Cells and Autoantibodies in Multiple Sclerosis.
Pröbstel AK; Sanderson NS; Derfuss T
Int J Mol Sci; 2015 Jul; 16(7):16576-92. PubMed ID: 26197319
[TBL] [Abstract][Full Text] [Related]
17. Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci.
Nexø BA; Villesen P; Nissen KK; Lindegaard HM; Rossing P; Petersen T; Tarnow L; Hansen B; Lorenzen T; Hørslev-Petersen K; Jensen SB; Bahrami S; Lajer M; Schmidt KL; Parving HH; Junker P; Laska MJ
Immunol Res; 2016 Feb; 64(1):55-63. PubMed ID: 26091722
[TBL] [Abstract][Full Text] [Related]
18. Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.
Elong Ngono A; Lepetit M; Reindl M; Garcia A; Guillot F; Genty A; Chesneau M; Salou M; Michel L; Lefrere F; Schanda K; Imbert-Marcille BM; Degauque N; Nicot A; Brouard S; Laplaud DA; Soulillou JP
J Immunol Res; 2015; 2015():673503. PubMed ID: 26090495
[TBL] [Abstract][Full Text] [Related]
19. Blood circulating microparticle species in relapsing-remitting and secondary progressive multiple sclerosis. A case-control, cross sectional study with conventional MRI and advanced iron content imaging outcomes.
Alexander JS; Chervenak R; Weinstock-Guttman B; Tsunoda I; Ramanathan M; Martinez N; Omura S; Sato F; Chaitanya GV; Minagar A; McGee J; Jennings MH; Monceaux C; Becker F; Cvek U; Trutschl M; Zivadinov R
J Neurol Sci; 2015 Aug; 355(1-2):84-9. PubMed ID: 26073484
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis.
Xiao J; Liu W; Chen Y; Deng W
J Neuroinflammation; 2015 Jun; 12():117. PubMed ID: 26068104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
